Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ELTX$1.55-2.52%
Elicio Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$40.74M
Float & O/S:
Inst Own:
DilutionScan read 24 of Elicio Therapeutics, Inc.'s SEC filings and found 8 warrant series, 1 convertible, 3 ATM programs, 5 shelf registrations and 1 completed offering on file for ELTX. The latest dilution event on file is ATM sales on Jul 2, 2026. Analysis updated Oct 7, 2026.
Signal8 Summary
ELTX
Cash crisis with 2-month runway
Snapshot
Elicio Therapeutics is a clinical-stage biotech with no revenue, burning through cash to fund cancer vaccine trials. The company lost $39.6 million in FY 2025 and generated $37 million in negative free cash flow. It holds $18.6 million in cash against $14.5 million in debt.
What's Happening Right Now
- : The company published a peer-reviewed manuscript in Science Advances highlighting potent immune responses driven by its AMP-DNA adjuvant technology in preclinical models.
- : Elicio raised $13 million in net proceeds through its at-the-market program in Q1 and Q2 2026 to extend its cash runway past the mid-year trial readout.
- : Analysts highlight a looming cash crisis as Elicio approaches a pivotal Phase 2 trial readout for its KRAS vaccine, making 2026 a critical year for the company's survival.
Raise routes on file: active ATM + effective shelf · latest dilution event 124 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 2, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
March 2024 Pre-Funded Warrants
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
July 2024 Pre-Funded Warrants
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Registered direct offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ELTX trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
